-
EP1743656
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1743656
| EP1743656 - Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.04.2011 Database last updated on 19.10.2024 | Most recent event Tooltip | 01.04.2011 | Application deemed to be withdrawn | published on 04.05.2011 [2011/18] | Applicant(s) | For all designated states Boehringer Ingelheim Pharma GmbH & Co. KG Binger Strasse 173 55216 Ingelheim am Rhein / DE | [2007/03] | Inventor(s) | 01 /
Baiker, Wolfgang.Dr. Kurt-Schumacher Str. 41 55546 Volxheim / DE | 02 /
Mehlburger, Ludwig.Dr. Heckengasse 5 55411 Bingen / DE | [2007/12] | Representative(s) | Hammann, Heinz Boehringer Ingelheim GmbH CD-Patents Binger Straße 173 55216 Ingelheim am Rhein / DE | [N/P] |
| Former [2009/48] | Hammann, Heinz Boehringer Ingelheim GmbH CD-Patents Binger Straße 173 55216 Ingelheim am Rhein / DE | ||
| Former [2007/03] | Hammann, Heinz Boehringer Ingelheim GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE | Application number, filing date | 06122312.9 | 17.04.2003 | [2007/03] | Priority number, date | DE2002118392 | 24.04.2002 Original published format: DE 10218392 | DE2002118611 | 25.04.2002 Original published format: DE 10218611 | [2007/03] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1743656 | Date: | 17.01.2007 | Language: | EN | [2007/03] | Type: | A3 Search report | No.: | EP1743656 | Date: | 07.03.2007 | [2007/10] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 06.02.2007 | Classification | IPC: | A61K45/06, A61K31/18, A61K31/56, A61P5/28, A61P13/08 | [2007/03] | CPC: |
A61K45/06 (EP,US);
A61K31/18 (EP,US);
A61K31/56 (EP,US);
A61P13/08 (EP);
A61P35/00 (EP);
A61P5/28 (EP)
| C-Set: |
A61K31/18, A61K2300/00 (EP,US);
A61K31/56, A61K2300/00 (US,EP) | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2007/03] | Extension states | LT | 07.09.2007 | LV | 07.09.2007 | Title | German: | pharmazeutische Kombination zur Behandlung von benigner Prostatahyperplasie oder zur Langzeitvorbeugung von akuter Harnretention | [2007/03] | English: | Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention | [2007/03] | French: | Combinaison pharmaceutique pour le traitement de l'hyperplasie prostatique benigne ou pour la prévention à long terme de la rétention urinaire aigue | [2007/03] | Examination procedure | 07.09.2007 | Examination requested [2007/43] | 05.11.2007 | Despatch of a communication from the examining division (Time limit: M06) | 16.08.2008 | Reply to a communication from the examining division | 03.11.2010 | Application deemed to be withdrawn, date of legal effect [2011/18] | 14.12.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2011/18] | Parent application(s) Tooltip | EP03725053.7 / EP1501517 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 18.08.2008 | Request for further processing filed | 18.08.2008 | Full payment received (date of receipt of payment) | Fees paid | Renewal fee | 16.02.2007 | Renewal fee patent year 03 | 16.02.2007 | Renewal fee patent year 04 | 02.05.2007 | Renewal fee patent year 05 | 02.05.2008 | Renewal fee patent year 06 | 04.05.2009 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 30.04.2010 | 08 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO0121167 (MERCK & CO INC [US], et al) [Y] 1-8 * claims 1-5 * * page 1, lines 6-12 * * page 1, lines 24-28 * * page 4, lines 6-11 *; | [E]WO03090753 (BOEHRINGER INGELHEIM PHARMA [DE], et al) [E] 4,6-8* claims 1-8 *; | [XY] - J.R.HORTON E.A., "No evidence of drug interactions between GI198745, a novel dual 5 alpha reductase inhibitor, and alpha 1 adrenergic antagonists", JOURNAL OF UROLOGY, (2000), vol. 163, no. sup4, pages 219 - 220, XP008019468 [X] 1-3,5-7 * page 219, column 2 * * page 220, column 1 * [Y] 1-8 | by applicant | EP0034432 | EP0155096 | US4760071 | US4772475 | EP0285382 | EP0285383 | WO9507927 | WO9510284 | - STEERS; ZORN, DIS. MON., (1995), vol. 41, no. 7, pages 437 - 497 |